Shawn Leland
Director/Board Member at Fore Biotherapeutics, Inc.
Shawn Leland active positions
| Companies | Position | Start | End |
|---|---|---|---|
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Director/Board Member | 2023-08-31 | - |
| Chief Executive Officer | 2023-08-31 | 2024-02-28 |
Career history of Shawn Leland
Former positions of Shawn Leland
| Companies | Position | Start | End |
|---|---|---|---|
| ELEVATION ONCOLOGY, INC. | Director/Board Member | 2018-12-31 | 2023-01-04 |
| Chief Executive Officer | 2020-11-17 | 2023-01-04 | |
| Founder | 2018-12-31 | 2023-01-04 | |
| Corporate Officer/Principal | 2018-12-31 | 2020-11-17 | |
| President | 2020-11-17 | 2023-01-04 | |
| VERASTEM, INC. | Corporate Officer/Principal | 2017-08-31 | 2019-07-31 |
| ARGOS THERAPEUTICS, INC. | Corporate Officer/Principal | 2013-10-31 | 2017-08-31 |
Training of Shawn Leland
| Albany College of Pharmacy & Health Sciences | Undergraduate Degree |
Statistics
International
| United States | 6 |
Operational
| Corporate Officer/Principal | 3 |
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ELEVATION ONCOLOGY, INC. | Health Technology |
| VERASTEM, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Argos Therapeutics, Inc.
 Argos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Argos Therapeutics, Inc. was a biopharmaceutical company. It engages in development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases based on its proprietary technology platform called Arcelis. The firm's product include AGS-003 for the treatment of metastatic renal cell carcinoma, and other cancers; and AGS-004 for the treatment of human immunodeficiency virus. The company was founded by Bruce A. Sullenger, Eli Gilboa, John A. Irick and Ralph M. Steinman on May 8, 1997 and was headquartered in Durham, NC. | Health Technology |
Fore Biotherapeutics, Inc.
Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Health Technology |
- Stock Market
- Insiders
- Shawn Leland
- Experience
